Twenty million shares hitting the market usually pushes insiders to the sidelines, but this CEO raised his personal stake 17% right into it.

Stay with this, and you will see why the integration math underneath supports the move.

Oil & Gas

Vista Energy (NYSE: VIST) trades near $71.70 after a filing showed Peter Thiel’s fund acquired roughly $76 million of the company. The fresh stake pushed shares higher, but the more important number sits underneath the move: Vista still trades around four times pro forma trailing adjusted EBITDA.

Second-quarter adjusted EBITDA jumped 99% to $805 million as revenue climbed 89% to $1.15 billion and production increased 32%. Adjusted EBITDA margin reached 70%, while lifting costs fell to $4.50 per barrel of oil equivalent, giving you unusually strong operating economics alongside the low enterprise multiple.

Vista also generated $491 million of Q2 free cash flow excluding an acquisition payment. Pro forma net leverage stands near 1.25 times adjusted EBITDA, so your valuation case is not dependent on an excessively leveraged balance sheet.

Production Growth Has More Room

Vista expects production to climb from roughly 158,000 barrels of oil equivalent per day in 2026 to 208,000 by 2028. If you get even part of that planned expansion without a major cost increase, today’s EBITDA multiple leaves room for substantial earnings growth.

Oil Prices Can Rewrite the Multiple

Vista realized $89.40 per barrel in Q2, meaning stronger crude prices helped drive the earnings surge. A sharp oil decline would reduce cash flow and make the apparent four-times EBITDA valuation less compelling, while the company still carries more than $3.6 billion of gross debt.

Mortgage REIT

PennyMac Mortgage Investment Trust (NYSE: PMT) trades near $9.73 after Deutsche Bank upgraded the stock to Buy and set a $12 price target. The call centers on valuation, with PMT now trading at roughly two-thirds of its $14.83 per-share book value.

The discount has widened even though book value declined only modestly during Q2. At today’s price, shares sit about 34% below book and near seven times trailing earnings, leaving you with a much steeper valuation reset than the underlying portfolio has experienced.

Management is also redirecting capital toward higher-return credit investments, completing six private-label securitizations totaling $2.2 billion during Q2. New investments in non-Agency subordinate bonds reached $120 million as PMT shifts away from lower-return assets.

The Portfolio Is Being Reworked

PMT agreed to sell $13 billion of mortgage servicing rights while increasing exposure to private-label securitizations and credit assets. Your valuation case improves if those moves lift earnings without creating another meaningful decline in book value.

The 16% Yield Comes With a Warning

The current $0.40 quarterly dividend exceeds Q2 earnings of $0.23 per share, and Deutsche Bank estimates the payout is covered by only about 80% of the current earnings run rate. If you are counting on the discount to close, a dividend cut remains the clearest near-term risk even if it ultimately puts the payout on firmer footing.

Government Technology

KBR Inc. (NYSE: KBR) trades near $37.91 after its Mission Technology Solutions business won a new five-year NATO contract worth up to $60 million. The award adds to a growing backlog in defense and government, while shares remain slightly down today.

Management still expects 2026 adjusted EPS of $3.87 to $4.22, putting the stock near 9.4 times the midpoint of guidance. KBR also expects $980 million to $1.04 billion of adjusted EBITDA, leaving the current valuation low relative to the earnings power it is already generating.

The larger catalyst sits ahead. KBR plans to separate Mission Technology Solutions into Trinzic in January 2027, creating a standalone business with more than $5 billion of annual revenue. You are paying a single-digit adjusted earnings multiple today for a company that could soon be valued as two separate businesses.

The Split Could Expose Hidden Value

Trinzic will contain KBR’s national security, space, digital, AI, and mission-engineering operations, while the remaining KBR keeps its sustainable technology portfolio. Your valuation case improves if the separation allows either business to command a higher standalone multiple than the combined company receives today.

Cash Conversion Still Needs to Catch Up

Adjusted operating cash flow fell sharply to $64 million in Q2 even though management maintained its $560 million to $600 million full-year outlook. If second-half collections disappoint, you lose one of the strongest supports behind the current low earnings multiple.

Primo Brands (NYSE: PRMB)

An affiliate of One Rock Capital announced a 20-million-share secondary offering on August 6. Four days later, Eric Foss bought 84,000 shares for $1,998,973 at a weighted average just under $24, lifting his personal stake 17.15% to 573,806 shares. Insiders now hold 32.9% of the company and have added $3.2 million over the past three months.

Buying into that kind of supply is not what executives typically do, which is precisely what makes it interesting. Primo is the platform that merged the old Primo Water and BlueTriton assets, so integration synergies are still working through the P&L while summer volumes have run ahead of Street models.

Morgan Stanley carries an Overweight with a $29 target against a price near $24.65, and eleven analysts rate it Buy against four Holds. The next quarterly update either confirms the synergy capture or it does not.

TG Therapeutics (NASDAQ: TGTX)

BRIUMVI is scaling, and management raised revenue guidance after Q2, which is the combination that turns a biotech from a hope trade into an arithmetic problem. The stock closed recently at $48.74 against a narrative fair value of $51.71, so you are not stealing it.

September script data and any international commercial wins are what widen or close that gap. Multiple sclerosis is a competitive category and pricing pressure is the obvious risk, but share gains have been holding. This one rewards watching the prescription trend more closely than the price chart.

Cypher Mining (NASDAQ: CIFR)

Nobody needs another bitcoin miner pitch, so here is the honest version. Cypher trades around $17.85 with a $7.3 billion market cap; fair value work puts it roughly 46% undervalued after a soft Q2, and revenue moves with bitcoin whether you like that or not.

Black Pearl Phase 1 is coming online, and Phase 2 is fully funded, which expands hash rate meaningfully into 2027. If crypto cooperates and the capacity lands on schedule, the math works. If the tape stays soft, you have paid for hash rate that produces less than modelled. Small position or none.

That's our coverage for today; thanks for reading! Reply to this email with feedback or any stocks you want me to check out.

Best Regards,
—Noah Zelvis
Undervalued Edge